XBiotech annual gross margin
2020
2021
2022
XBiotech Gross Margin Growth & History (XBIT)
XBiotech's gross margin was 83.77% for fiscal 2022.
View full XBiotech company overviewXBiotech annual gross margin history
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2022 | 2022-12-31 | 83.77% | +15.41 pp |
| 2021 | 2021-12-31 | 68.36% | +46.88 pp |
| 2020 | 2020-12-31 | 21.48% | — |
XBiotech quarterly gross margin
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q4 2022 | 2022-12-31 | 94.67% | +17.91 pp |
| Q3 2022 | 2022-09-30 | 87.20% | +11.77 pp |
| Q2 2022 | 2022-06-30 | 86.47% | +16.53 pp |
| Q1 2022 | 2022-03-31 | 57.40% | +4.91 pp |
| Q4 2021 | 2021-12-31 | 76.76% | +19.40 pp |
| Q3 2021 | 2021-09-30 | 75.44% | +64.79 pp |
| Q2 2021 | 2021-06-30 | 69.94% | +55.12 pp |
| Q1 2021 | 2021-03-31 | 52.49% | +28.78 pp |
| Q4 2020 | 2020-12-31 | 57.35% | — |
| Q3 2020 | 2020-09-30 | 10.65% | — |
| Q2 2020 | 2020-06-30 | 14.82% | — |
| Q1 2020 | 2020-03-31 | 23.71% | — |
XBiotech gross margin trends
Across the available reported history, XBiotech's gross margin increased from 68.36% to 83.77%, a change of +15.41 percentage points. The latest reported quarter, Q4 2022, shows 94.67%.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review XBiotech filings at SEC.gov ↗